Study: Most patients want to be told about cancer drug shortages, substitutions

Low supplies of cancer drugs pose a common obstacle to oncology care, yet few Americans are aware of these shortages, according to a study published in Cancer.

Advertisement

For the study, researchers polled a nationally representative group of 420 respondents on cancer drug shortages in 2016. Gregory Abel, MD, MPH, and Zachary Frosch, MD, physicians affiliated with Boston-based Brigham and Women’s Hospital and the Dana-Farber Cancer Institute, spearheaded the research.

Here are four study findings.

1. Sixteen percent of respondents said they were aware of drug shortages. Individuals with a personal history of cancer were more likely to be aware of shortages (31 percent versus 14 percent).

2. Most respondents wanted to be informed about a medication substitution due to a shortage. Eighty-seven percent and 82 percent wanted to know about major or minor differences in the drugs’ efficacy, respectively.

3. A majority (72 percent) of respondents said they would transfer care to avoid a substitution with major efficacy differences, and 61 percent would transfer for major differences in side effects.

4. Black, uninsured, unemployed, low-income and less-educated individuals were not as likely to transfer care to avoid major differences in drug efficacy.

“It can be stressful for patients with cancer to learn that their care may be impacted by drug shortages, but it’s important for oncologists to engage patients in these discussions,” said Dr. Frosch. “Our data suggest that people expect disclosure of shortages as part of the caregiving process.”

More articles on supply chain:

Meet Medtronic’s new vice president of clinical research and analytics
Pharma gave patient groups $116M in 1 year: 4 findings
Amazon global leader in R&D expenditure at nearly $22.6B

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.